SPC
NARI

Slate Path Capital’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Slate Path Capital’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-418,000
Closed -$20.1M – 77
2024
Q1 		$20.1M Hold
418,000
– – 0.4% 42
2023
Q4 		$27.1M Buy
+418,000
New +$25.2M 0.6% 39

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Slate Path Capital's NARI Position: Q2 2024 in Review

Slate Path Capital sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2024, closing a stake of 418,000 shares — an estimated $20.1M sold.

Slate Path Capital first reported a position in NARI in Q4 2023 and held it in 2 quarters. The position peaked at $27.1M in Q4 2023. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

  • Slate Path Capital reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Slate Path Capital sold 418,000 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $20.1M.
  • Slate Path Capital first reported a position in Inari Medical, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
  • Slate Path Capital's Inari Medical, Inc. Common Stock position peaked at $27.1M in Q4 2023.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Slate Path Capital's 13F filing for Q2 2024, filed 14 Aug 2024.